Log in
Enquire now
‌

US Patent 9771363 Heterocyclic compounds and uses thereof

Patent 9771363 was granted and assigned to Plexxikon Inc. on September, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Plexxikon Inc.
Plexxikon Inc.
0
Date Filed
September 19, 2016
0
Date of Patent
September 26, 2017
0
Patent Applicant
Plexxikon Inc.
Plexxikon Inc.
0
Patent Application Number
15269054
0
Patent Citations Received
‌
US Patent 12122833 Combination therapies of HDAC inhibitors and PD-1 inhibitors
0
‌
US Patent 12076322 Compounds and methods for kinase modulation, and indications therefor
0
Patent Inventor Names
Wayne Spevak
0
Ben Powell
0
Jiazhong Zhang
0
Prabha N. Ibrahim
0
Songyuan Shi
0
Yan Ma
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
9771363
0
Patent Primary Examiner
‌
Charanjit Aulakh
0

Find more entities like US Patent 9771363 Heterocyclic compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.